Belsomra and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Belsomra (suvorexant) and Restoril (temazepam). Common drug interactions include knee arthroplasty among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Belsomra and Restoril. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 28, 2026

23 people who take Belsomra and Restoril together, and have interactions are studied.

Belsomra and Restoril drug interactions.

What are the common drug interactions of Belsomra and Restoril, by gender? *:

female:

  1. Knee arthroplasty
  2. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Adverse event
  5. Agitation (state of anxiety or nervous excitement)
  6. Anxiety
  7. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  8. Depression
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Fall

male:

  1. Drug ineffective
  2. Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
  3. Therapeutic response unexpected
  4. Weight increased
  5. Abnormal dreams
  6. Aggression
  7. Blood sodium increased

What are the common drug interactions of Belsomra and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Aggression

50-59:

  1. Drug ineffective
  2. Adverse event
  3. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  4. Fall
  5. Hypertension (high blood pressure)
  6. Muscle injury
  7. Muscle twitching
  8. Renal failure (kidney dysfunction)
  9. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  10. Synovial cyst (cyst of joint filled with synovial fluid)

60+:

  1. Drug ineffective
  2. Constipation
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Knee arthroplasty
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Abnormal dreams
  8. Agitation (state of anxiety or nervous excitement)
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Sleep Disorder: 6 people, 26.09%
  2. Pain: 4 people, 17.39%
  3. Stress And Anxiety: 2 people, 8.70%
  4. Neuralgia (pain in one or more nerves): 2 people, 8.70%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.70%
  6. Impaired Gastric Emptying: 2 people, 8.70%
  7. Hypotension (abnormally low blood pressure): 2 people, 8.70%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Belsomra and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Belsomra and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Belsomra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Belsomra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on suvorexant and temazepam (the active ingredients of Belsomra and Restoril, respectively), and Belsomra and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: